Literature DB >> 3011655

Interaction between herpes simplex type 1-induced Fc receptor and human and rabbit immunoglobulin G (IgG) domains.

P J Johansson, A K Schröder, F A Nardella, M Mannik, P Christensen.   

Abstract

Cells infected with herpes simplex virus type 1 (HSV-1) express a cell surface receptor able to bind to the Fc region of immunoglobulin G (IgG). The ability of HSV-1-infected cells to bind 125I-labelled human and rabbit IgG and IgG fragments was studied to localize the site of interaction to the C gamma 2 or C gamma 3 domains of IgG. 125I-labelled IgG and IgG Fc fragments consisting of C gamma 2 and C gamma 3 domains bound strongly to HSV-infected cells and did not bind to uninfected cells. In contrast, 125I-labelled F(ab')2, Facb [consisting of F(ab')2 and C gamma 2 domains] and pFc' (consisting of C gamma 3 domains) fragments did not bind to any of these cells. Unlabelled IgG and IgG Fc fragments inhibited the interaction between 125I-labelled rabbit IgG Fc and the HSV Fc receptor, whereas F(ab')2, Facb and pFc' fragments failed to inhibit this interaction. These data indicate that the HSV Fc receptor requires both the C gamma 2 and C gamma 3 domains for interaction with the IgG molecule analogous to the known interaction of protein A of Staphylococcus aureus, the Fc binding proteins of Group A, C and G streptococci, and certain human rheumatoid factors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011655      PMCID: PMC1452668     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

2.  Quantitation of the uptake of human IgG by some streptococci groups A, B, C, and G.

Authors:  P Christensen; V A Oxelius
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-08

3.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

4.  Subfragments from the Fc fragment of human immunoglobulin G. Isolation and physicochemical charaterization.

Authors:  M W Turner; H Bennich
Journal:  Biochem J       Date:  1968-03       Impact factor: 3.857

5.  A rapid slide-agglutination method for typing pneumococci by means of specific antibody adsorbed to protein A-containing staphylococci.

Authors:  G Kronvall
Journal:  J Med Microbiol       Date:  1973-05       Impact factor: 2.472

6.  Differences in anti-protein A activity among IgG subgroups.

Authors:  G Kronvall; R C Williams
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

7.  Enzymatic iodination of polypeptides with 125I to high specific activity.

Authors:  J I Thorell; B G Johansson
Journal:  Biochim Biophys Acta       Date:  1971-12-28

8.  An enzymic method for the trace iodination of immunoglobulins and other proteins.

Authors:  J J Marchalonis
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

9.  Detection by indirect immunofluorescence of Fc receptors in cells acutely infected with Herpes simplex virus.

Authors:  P M Feorino; S L Shore; C B Reimer
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

10.  Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis.

Authors:  R Adler; J C Glorioso; J Cossman; M Levine
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

View more
  10 in total

1.  Identification of the site on IgG Fc for interaction with streptococci of groups A, C and G.

Authors:  A K Schröder; F A Nardella; M Mannik; P J Johansson; P Christensen
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

Review 2.  Rheumatoid factors in immune complexes of patients with rheumatoid arthritis.

Authors:  M Mannik; F A Nardella; E H Sasso
Journal:  Springer Semin Immunopathol       Date:  1988

Review 3.  Possible role of microbial IgG Fc-binding proteins in rheumatoid arthritis.

Authors:  P Christensen; A K Schröder
Journal:  Agents Actions       Date:  1990-01

4.  Herpes simplex type 1-induced Fc receptor binds to the Cgamma2-Cgamma3 interface region of IgG in the area that binds staphylococcal protein A.

Authors:  P J Johansson; F A Nardella; J Sjöquist; A K Schröder; P Christensen
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

5.  A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.

Authors:  I Frank; H M Friedman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

6.  Studies of protein A and herpes simplex virus-1 induced Fc gamma-binding specificities. Different binding patterns for IgG3 from Caucasian and Oriental subjects.

Authors:  P J Johansson; T Ota; N Tsuchiya; C C Malone; R C Williams
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

7.  Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity.

Authors:  G Dubin; E Socolof; I Frank; H M Friedman
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI.

Authors:  V Litwin; W Jackson; C Grose
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

9.  Human rheumatoid factors bear the internal image of the Fc binding region of staphylococcal protein A.

Authors:  I R Oppliger; F A Nardella; G C Stone; M Mannik
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

10.  Fv structure of monoclonal antibody II-481 against herpes simplex virus Fc gamma-binding glycoprotein gE contains immunodominant complementarity determining region epitopes that react with human immunoglobulin M rheumatoid factors.

Authors:  P J Johansson; C Malone; W Swietnicki; B M Dunn; R C Williams
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.